.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Chubb
McKinsey
Harvard Business School
Teva
Argus Health
Federal Trade Commission
US Department of Justice
QuintilesIMS
US Army

Generated: September 20, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 077463

« Back to Dashboard
NDA 077463 describes NATEGLINIDE, which is a drug marketed by Zydus Pharms Usa Inc, Alvogen Malta, Dr Reddys Labs Ltd, Watson Labs, Par Pharm, and Teva Pharms, and is included in six NDAs. It is available from eleven suppliers. Additional details are available on the NATEGLINIDE profile page.

The generic ingredient in NATEGLINIDE is nateglinide. There are nine drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the nateglinide profile page.

Summary for NDA: 077463

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Blood Glucose Regulators
Formulation / Manufacturing:see details

Pharmacology for NDA: 077463

Mechanism of ActionPotassium Channel Antagonists

Suppliers and Packaging for NDA: 077463

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NATEGLINIDE
nateglinide
TABLET;ORAL 077463 ANDA NCS HealthCare of KY, Inc dba Vangard Labs 0615-7585 0615-7585-39 30 TABLET, COATED in 1 BLISTER PACK (0615-7585-39)
NATEGLINIDE
nateglinide
TABLET;ORAL 077463 ANDA NCS HealthCare of KY, Inc dba Vangard Labs 0615-7586 0615-7586-39 30 TABLET, COATED in 1 BLISTER PACK (0615-7586-39)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength60MG
Approval Date:Sep 9, 2009TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength120MG
Approval Date:Sep 9, 2009TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Teva
AstraZeneca
Fuji
Medtronic
Mallinckrodt
Boehringer Ingelheim
Cantor Fitzgerald
Baxter
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot